MC
Methods of Care

Thursday, May 31, 2018: 6:30 PM-7:30 PM
Exhibit Hall A (Nashville Music City Center)
Seroconversion of Serum Nmo IgG in Initial Seronegative Nmo IgG and Positive CSF Nmo IgG Antibody Neuromyelitis Optica Case
Deepmala Nandanwar, MD, Wayne State University / Detroit Medical Center; Evanthia Bernitsas, MD, Wayne State University School of Medicine
PDF
Factors Influencing Best Practices in Treating Multiple Sclerosis: Results from a Predictive Modeling Analysis
Jamie Reiter, PhD, CME Outfitters, LLC; Jan Perez, BS, CME Outfitters, LLC; Sharon Tordoff, BS, CME Outfitters, LLC; Whitney Faler, MPA, CME Outfitters, LLC

Association of 30-Day Continuity of Care with Outcomes in Multiple Sclerosis
Kanika Sharma, MD, University of Iowa; Yubo Gao, PhD, University of Iowa; Junlin Liao, PhD, University of Iowa; John A Kamholz, MD, PhD, University of Iowa; Frank R Bittner, DO, University of Iowa
PDF
Implementing a Brain Health-Focused Approach to Multiple Sclerosis Care: Global and Local MS Brain Health Initiatives
Jodi Haartsen, Master of Nursing, Post Graduate Diploma of Neuroscience Nursing, Graduate Diploma of Applied Science, Eastern Health; Jeremy Hobart, BSc PhD FRCP Dip Public Health, Plymouth University Peninsula Schools of Medicine and Dentistry; Amy Bowen, CBiol MRSB (Chartered Biologist, Member of the Royal Society of Biology), NHS RightCare; Lucy Eberhard, PhD, PharmaGenesis London; George Pepper, -, Shift.ms; Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry

Can We Move the Wellness "Needle" with Shared Medical Appointments for MS Patients?
Mary R Rensel, MD, FAAN, Cleveland Clinic; S. Bassi, BS, CWRU
PDF
An MS Academic Center Experience with Ocrelizumab and Implications for Increasing Staffing Needs
Brooke McCartney, BSN, RN, UT Southwestern Medical Center; Paula Hardeman, PA-C, UT Southwestern Medical Center; Benjamin Greenberg, MD, MHS, UT Southwestern

Burnaby Electronic Tool for Safety Monitoring of Patients on MS Disease Modifying Therapies (BESAFE DMT)
Jill R Nelson, RN BScN MSCN, Fraser Health Multiple Sclerosis Clinic; Anna Kazimirchik, RN MSCN, Fraser Health Multiple Sclerosis Clinic; Tatstsyana Kadach, MEng, Fraser Health Multiple Sclerosis Clinic; Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic

The Clinical Research Navigator: A Novel Role and Its Impact on Research Participation By Clinic Patients.
Danielle M Taylor, BA, Weill Institute for Neurosciences; Refujia Gomez, BS, Weill Institute for Neurosciences; Amber Alexander, MSc, MS Research Coordinators; Jennifer Arjona, BA, MS, MS Research Coordinators; Sergio Baranzini, PhD, Weill Institute for Neurosciences; Patrick Barba, BS, MS EPIC Team; Bruce AC Cree, MD, PhD, Weill Institute for Neurosciences; Michael Devereux, B.S., MS Research Coordinators; Samuel Friedman, BS, MS Research Coordinators; Priya Garcha, BSc, MS Research Coordinators; Jeffrey M Gelfand, MD, MAS, Weill Institute for Neurosciences; Douglas S. Goodin, MD, Weill Institute for Neurosciences; Jennifer S Graves, M.D. PhD, Weill Institute for Neurosciences; Ari J Green, MD, Weill Institute for Neurosciences; Ariele Greenfield, MD, Weill Institute for Neurosciences; Stephen L Hauser, MD, UCSF Neurology, Weill Institute for Neurosciences; Roland Henry, PhD, Weill Institute for Neurosciences; Xiaoming Jia, MD, Weill Institute for Neurosciences; Liana Kanaaneh, BA, MS Research Coordinators; Kristen Krysko, MD, Weill Institute for Neurosciences; Robin Lincoln, BS, UCSF Neurology, Weill Institute for Neurosciences; Michael Manguinao, BS, MS Research Coordinators; Naomi Okinishi, MPH, MS Research Coordinators; Jorge Oksenberg, PhD, Weill Institute for Neurosciences; Samuel Pleasure, MD, PhD, Weill Institute for Neurosciences; Nicholas Ragan, BSc, MS EPIC Team; Nisha Revirajan, MD, MS Research Coordinators; Andrew Romeo, MD, Weill Institute for Neurosciences; Gillian Rush, BSc, MS EPIC Team; Joseph Sabatino Jr., MD, PhD, Weill Institute for Neurosciences; Ryan Schubert, MD, Weill Institute for Neurosciences; Nancy Shum, BS, MS Research Coordinators; Sneha Singh, BSc, MS Research Coordinators; Collin Spencer, BS, MS Research Coordinators; Emmanuelle Waubant, MD, PhD, Weill Institute for Neurosciences; Michael Wilson, MD, Weill Institute for Neurosciences; Scott Zamvil, MD, PhD, Weill Institute for Neurosciences; Riley Bove, MD, MMSc, UCSF Neurology, Weill Institute for Neurosciences

Clinic to in-Home Telemedicine Reduces Barriers to Care for Patients with Multiple Sclerosis and Neuroinflammation
Priya Garcha, BSc, Weill Institute for Neurosciences; Carolyn J Bevan, MD, Weill Institute for the Neurosciences; Elizabeth Crabtree-Hartman, MD, MAS, Weill Institute for the Neurosciences; Ari J Green, MD, Weill Institute for Neurosciences; Jeffrey M Gelfand, MD, MAS, Weill Institute for Neurosciences; Riley Bove, MD, MMSc, Weill Institute for Neurosciences

Validating Unsupervised Digital Cognitive Evaluations and Training Tools in Multiple Sclerosis
Priya Garcha, BSc, Weill Institute for Neurosciences; Gillian Rush, BSc, Weill Institute for Neurosciences; John Morrissey, BSc, Weill Institute for Neurosciences; Chao Zhao, MSc, Weill Institute for Neurosciences; Katherine Possin, PhD, Weill Institute for Neurosciences; Anthony Feinstein, PhD, MD, University of Toronto; Joaquin Anguera, PhD, Weill Institute for Neurosciences; Riley Bove, MD, MMSc, Weill Institute for Neurosciences

A Retrospective, Single Institution Study of Tumefactive Multiple Sclerosis
Anastasie Dunn-Pirio, MD, MS, Duke University; Suma Shah, MD, Duke University; Christopher Eckstein, MD, Duke University
PDF
See more of: Poster